Search Results - "Mahmut TÖBÜ"
-
1
Real-Life Experience with Pomalidomide plus Dexamethasone in Patients with Multiple Myeloma: A Single Center Retrospective Study
Published in Hematology, Transfusion and Cell Therapy (01-05-2024)“…Objective: Multiple myeloma (MM) is a heterogeneous disease with the uncontrolled clonal proliferation of plasma cells, accounting for approximately 10% of all…”
Get full text
Journal Article -
2
PB1937: A RARE, DIFFICULT‐ TO‐ DIAGNOSE DISEASE; LANGERHANS CELL HISTIOCYTOSIS – A SINGLE CENTRE EXPERIENCE
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
3
Does immunohistochemical staining predict mobilization success in multiple myeloma patients?
Published in Transfusion and apheresis science (01-12-2024)“…So many risk factors for mobilization failure have been described so far. We aimed to identify the risk factors and search the possible effects of bone marrow…”
Get full text
Journal Article -
4
A complex t(15;22;17)(q22;q11.2;q21) variant of APL
Published in Cancer genetics (01-08-2024)“…The present study described an extremely rare case of acute promyelocytic leukemia (APL) characterized by a complex three‑way (15;22;17)(q22;q11.2;q21)…”
Get full text
Journal Article -
5
The Effect of Cryotherapy on the Prevention of Oral Mucositis and on the Oral pH Value in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Published in Seminars in oncology nursing (01-06-2021)“…•What is already known about this topic?•Oral mucositis (OM) is still a serious problem for patients receiving hematopoietic stem cell transplantation…”
Get full text
Journal Article -
6
Factor V G1691A (Leiden) and prothrombiG20210A gene mutation status, and thrombosis in patients with chronic myeloproliferative disorders
Published in Turkish journal of haematology (05-12-2011)“…The aim of this study was to examine Factor V G1691A (Leiden) (FVL) and prothrombin G20210A (PT) gene mutation status, and their relationship with thrombosis…”
Get full text
Journal Article -
7
Report on Three Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm
Published in Turkish journal of haematology (2018)“…To the Editor, Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, clinically aggressive tumor that was classified as a distinct entity among…”
Get full text
Journal Article -
8
CT-230 Evaluation of BK Polyomavirus Infection Frequency and Risk Factors Following Allogeneic Stem Cell Transplantation (allo-SCT): A Single Center Experience
Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)“…Hemorrhagic cystitis (HC) is a clinical entity that mostly occurs after allo-SCT and reduces the quality of life of patients, prolongs hospitalization and…”
Get full text
Journal Article -
9
CT-232 Evaluation of the Effects of Cytomegalovirus and BK Polyomavirus Infections on Overall Survival Following Allogeneic Stem Cell Transplantation: A Single Center Experience
Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)“…This study aims to investigate the impact of cytomegalovirus (CMV) infection, CMV disease, and development of BK polyomavirus-associated hemorrhagic cystitis…”
Get full text
Journal Article -
10
-
11
-
12
-
13
CT-127 Evaluation of Cytomegalovirus Infection/Disease Frequency and Risk Factors Following Allogeneic Stem Cell Transplantation: A Single Center Experience
Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)“…The objective of this retrospective, observational study was to investigate the frequency of cytomegalovirus (CMV) infection and CMV disease in adult patients…”
Get full text
Journal Article -
14
Progressive Transformation of Germinal Centers: Single Center Experience of 33 Turkish Patients
Published in Clinical lymphoma, myeloma and leukemia (01-08-2016)“…Abstract Background Progressive transformation of germinal centers (PTGC) is a benign disease of the lymph nodes which is rarely associated with Hodgkin…”
Get full text
Journal Article -
15
Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey
Published in Turkish journal of medical sciences (28-06-2021)“…The aim of this study is to assess the efficacy and safety of ruxolitinib in patients with myelofibrosis. From 15 centers, 176 patients (53.4% male, 46.6%…”
Get full text
Journal Article -
16
-
17
CT-129 A Rare, Challenging Disease: Langerhans Cell Histiocytosis, a Single-Center Experience
Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)“…The objective of this retrospective study was to analyze the diagnostic procedures, clinical course, and treatment outcomes of patients with Langerhans cell…”
Get full text
Journal Article -
18
POSTER: CT-129 A Rare, Challenging Disease: Langerhans Cell Histiocytosis, a Single-Center Experience
Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)Get full text
Journal Article -
19
Carfilzomib experience in relapsed/refractory multiple myeloma: a single-center experience
Published in Turkish journal of medical sciences (23-02-2018)“…Background/aim: Carfilzomib (CFZ) is a new-generation proteasome inhibitor with significant activity in relapsed or refractory multiple myeloma (R/R-MM). We…”
Get full text
Journal Article -
20
Pleural Effusion Formation in the Course of Myeloma
Published in Archivos de bronconeumología (English ed.) (01-08-2015)Get full text
Journal Article